Table 2.
Quality criteria | All sites (n=75) | Professionals* (n=25) | Organisations † (n=25) | Commercial sites (n=25) |
---|---|---|---|---|
Types of incontinence | 1.9 (1.6 to 2.2) | 2.1 (1.7 to 2.6) | 2.0 (1.6 to 2.5) | 1.5 (0.9 to 2.1) |
Epidemiology | 1.6 (1.3 to 1.8) | 1.5 (1.1 to 1.9) | 1.9 (1.4 to 2.4) | 1.3 (1.0 to 1.6) |
Pelvic floor exercises | 1.4 (1.2 to 1.6) | 1.2 (1.0 to 1.5) | 1.8 (1.4 to 2.2) | 1.2 (0.8 to 1.5) |
Surgery | 1.1 (0.9 to 1.4) | 1.5 (1.1 to 1.9) | 1.2 (0.9 to 1.6) | 0.7 (0.3 to 1.0) |
Investigations | 1.1 (0.8 to 1.3) | 1.5 (1.0 to 1.9) | 1.3 (0.8 to 1.8) | 0.4 (0.0 to 0.8) |
Pads | 1.0 (0.8 to 1.2) | 0.7 (0.4 to 1.0) | 1.0 (0.6 to 1.4) | 1.3 (0.8 to 1.8) |
Electrostimulation | 0.9 (0.6 to 1.1) | 0.7 (0.4 to 1.1) | 1.0 (0.5 to 1.4) | 0.9 (0.3 to 1.4) |
Collagen injections | 0.8 (0.5 to 1.0) | 1.2 (0.6 to 1.7) | 0.7 (0.3 to 1.2) | 0.4 (0.0 to 0.8) |
Drugs that may cause incontinence | 0.5 (0.4 to 0.7) | 0.3 (0.0 to 0.6) | 0.9 (0.5 to 1.3) | 0.4 (0.1 to 0.6) |
Oestrogen | 0.5 (0.3 to 0.7) | 0.6 (0.2 to 0.9) | 0.8 (0.3 to 1.2) | 0.3 (0.0 to 0.5) |
α adrenergic agonists | 0.5 (0.3 to 0.6) | 0.4 (0.1 to 0.7) | 0.7 (0.3 to 1.1) | 0.3 (0.0 to 0.6) |
Urethral plugs or shields | 0.5 (0.2 to 0.7) | 0.4 (0.0. to 0.8) | 0.5 (0.0 to 0.9) | 0.5 (0.0 to 0.9) |
Pessaries | 0.4 (0.2 to 0.6) | 0.3 (0.0 to 0.6) | 0.6 (0.2 to 1.1) | 0.3 (0.0 to 0.7) |
Vaginal cones | 0.4 (0.2 to 0.6) | 0.2 (0.0 to 0.4) | 0.7 (0.3 to 1.1) | 0.3 (0.0 to 0.7) |
Websites of universities, hospitals, and clinics. †Websites of societies, foundations, and journals.